Inhibition of Bradykinin in COVID-19 Infection With Icatibant

Clinical trial NCT05407597 · COMPLETED

Trial details

NCT number: NCT05407597
Sponsor: Belfast Health and Social Care Trust
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

SARS CoV 2 Infection

Start date: 2022-05-16
Primary completion: 2023-06-09
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.